4-HNE |
4-hydroxynonenal |
AMPK |
5′-adenosine monophosphate (AMP)-activated protein kinase |
ASCO |
American Society of Clinical Oncology |
BPI-SF |
Brief Pain Inventory-Short Form |
CAT |
catalase |
CBP |
CREB binding protein |
CIPN |
chemotherapy induced peripheral neuropathy |
CK2 |
casein kinase 2 |
CIT |
chemotherapy-induced toxicity |
COX-2 |
cyclooxygenase-2 |
CTCAE |
Common Toxicity Criteria for Adverse Events |
EGFR |
epidermal growth factor receptor |
EpRE |
electrophile-responsive elements |
ER |
endoplasmic reticulum |
GSH-Px |
glutathione peroxidase |
H2O2
|
hydrogen peroxide |
HDAC3 |
histone deacetylase 3 |
HO• |
hydroxyl radical |
HO-1 |
heme oxygenase-1 |
HSI |
hyperspectral imaging |
ICAM |
intracellular adhesion molecule |
IKK |
IκB kinase |
IL |
interleukin |
iNOS |
inducible nitric oxide synthase |
Keap1 |
Kelch-like ECH-associated protein 1 |
MDA |
Malondialdehyde |
miRNA |
microRNA |
NF-κB |
nuclear factor kappa B |
NPSI |
Neuropathic Pain Symptom Inventory |
NQO1 |
NADPH quinone oxidoreductase |
Nrf2 |
nuclear factor erythroid 2-related factor |
O2
|
oxygen |
O2•− |
superoxide anion radical |
O3
|
ozone |
OH• |
hydroxyl radical |
OS |
oxidative stress |
PDE2A |
phosphodiesterase 2A |
PLA2 |
phospholipase A2 |
PUFA |
polyunsaturated fatty acids |
RCT |
randomized controlled trial |
ROS |
reactive oxygen species |
SOD |
superoxide dismutase |
TGF-β1 |
transforming growth factor β1 |
TNF-α |
tumor necrosis factor-alpha |
TRP |
transient receptor potential channel |
TRPA1 |
transient receptor potential ankyrin-repeat 1 channel |
VAS |
Visual Analog Scale |